epocrates logo
epocrates logo
epocrates logo
  • 0

Journal Article Synopsis

Lancet Public Health

7,000 daily steps associated with substantial reductions in mortality and chronic disease risk

July 29, 2025

card-image

Achieving 7,000 steps/day is associated with clinically meaningful reductions in mortality and multiple chronic disease risks, supporting its use as a realistic and evidence-based physical activity target for adults. These findings reinforce the utility of step-based goals in clinical counseling and public health, while acknowledging limitations such as limited age-specific data and potential residual confounding.

Study details: This systematic review and dose-response meta-analysis synthesized prospective studies (2014–2025) examining device-measured daily steps and a broad range of health outcomes in adults, including all-cause mortality, CVD, cancer, T2DM, cognitive and mental health, physical function, and falls. Fifty-seven studies from 35 cohorts were included in the review, with 31 studies from 24 cohorts contributing to meta-analyses. Certainty of evidence was assessed using GRADE.

Results: An inverse, non-linear association was observed for all-cause mortality, CVD incidence, dementia, and falls, with inflection points at approximately 5,000–7,000 steps/day. For CVD mortality, cancer incidence/mortality, T2DM, and depressive symptoms, the association was inverse and linear. Compared with 2,000 steps/day, 7,000 steps/day was associated with a 47% lower risk of all-cause mortality (hazard ratio, 0.53; 95% confidence interval, 0.46–0.60), 25% lower CVD incidence, 47% lower CVD mortality, 37% lower cancer mortality, 14% lower T2DM incidence, 38% lower dementia risk, 22% lower depressive symptoms, and 28% lower fall risk. Certainty of evidence was moderate for most outcomes, but lower for CVD mortality, cancer incidence, physical function, and falls.

Source:

Ding D, et al. (2025, July 17). Lancet Public Health. Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis. https://pubmed.ncbi.nlm.nih.gov/40713949/

learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information